{"product_id":"tirzepatide","title":"Tirzepatide (Dual Agonist | GLP-1 \/ GIP | Metabolic Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eTirzepatide has been studied extensively in human clinical trials as a \u003cstrong\u003edual GIP\/GLP-1 receptor agonist\u003c\/strong\u003e. In approved medical settings, it is used as a once-weekly injectable medication for type 2 diabetes under the brand \u003cstrong\u003eMounjaro\u003c\/strong\u003e, and for chronic weight management under \u003cstrong\u003eZepbound\u003c\/strong\u003e in some countries. Its main research interest comes from its ability to activate two incretin pathways involved in glucose control, appetite signaling, insulin response, gastric emptying, and body-weight regulation.\u003c\/p\u003e\n\u003ch3\u003ePotential benefits observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSignificant body-weight reduction\u003c\/strong\u003e\u003cbr\u003eIn obesity studies, tirzepatide produced substantial average weight loss compared with placebo. SURMOUNT-1 reported body-weight reductions in the range of about \u003cstrong\u003e16% to 22.5%\u003c\/strong\u003e, depending on dose group.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImproved glycemic control\u003c\/strong\u003e\u003cbr\u003eIn type 2 diabetes studies, tirzepatide has shown strong reductions in \u003cstrong\u003eHbA1c\u003c\/strong\u003e, fasting glucose, and overall markers of blood-sugar control. SURPASS trial analyses describe consistent reductions in both HbA1c and body weight across studied doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eDual-pathway metabolic activity\u003c\/strong\u003e\u003cbr\u003eBecause tirzepatide activates both \u003cstrong\u003eGIP\u003c\/strong\u003e and \u003cstrong\u003eGLP-1\u003c\/strong\u003e receptors, it gives researchers a way to study combined incretin signaling rather than GLP-1 activity alone.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite and satiety pathway effects\u003c\/strong\u003e\u003cbr\u003eHuman studies suggest tirzepatide can influence appetite regulation, food intake behavior, and satiety signaling, which may contribute to weight-related outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential cardiometabolic improvements\u003c\/strong\u003e\u003cbr\u003eWeight loss and glycemic improvement may also be associated with improvements in metabolic markers such as waist circumference, blood pressure, insulin sensitivity, and lipid-related parameters, depending on the study population.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOnce-weekly dosing in approved formulations\u003c\/strong\u003e\u003cbr\u003eIts long-acting structure supports once-weekly administration in approved pharmaceutical products, which is one reason it is widely studied in metabolic medicine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal side effects are common\u003c\/strong\u003e\u003cbr\u003eNausea, diarrhea, vomiting, constipation, abdominal discomfort, and decreased appetite are among the most commonly reported effects. These often occur during dose escalation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot suitable for everyone\u003c\/strong\u003e\u003cbr\u003eFDA labeling lists contraindications for people with a personal or family history of \u003cstrong\u003emedullary thyroid carcinoma\u003c\/strong\u003e or \u003cstrong\u003eMEN 2\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRequires medical supervision when used clinically\u003c\/strong\u003e\u003cbr\u003eIn human use, tirzepatide should only be used as an approved medication prescribed and monitored by a licensed healthcare professional. It is not appropriate to use research-grade or unapproved peptide products in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential for dehydration or kidney-related issues\u003c\/strong\u003e\u003cbr\u003eSevere vomiting or diarrhea can increase dehydration risk, which may worsen kidney function in vulnerable patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible gallbladder and pancreatitis concerns\u003c\/strong\u003e\u003cbr\u003eGLP-1–based therapies are commonly monitored for symptoms related to gallbladder disease and pancreatitis risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWeight regain can occur after discontinuation\u003c\/strong\u003e\u003cbr\u003eLike many chronic metabolic treatments, benefits may decrease when therapy stops, especially without sustained lifestyle and medical management.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical data on tirzepatide is promising, especially for metabolic and weight-related outcomes, but human use should only involve approved, regulated medication under licensed medical supervision. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51939087221024,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 15mg","offer_id":51939087253792,"sku":null,"price":2100.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 30mg","offer_id":51939087286560,"sku":null,"price":2500.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 15mg","offer_id":51939282583840,"sku":null,"price":3800.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 30mg","offer_id":51939282616608,"sku":null,"price":4300.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/7c3c37f9-8903-42ed-90c0-e38d808e2b4a.png?v=1783142957","url":"https:\/\/sterilelabs.shop\/products\/tirzepatide","provider":"Sterile Labs","version":"1.0","type":"link"}